[Clinical practice guideline for lung cancer].
A clinical practice guideline for lung cancer in Japan was published by an expert multidisciplinary panel in 2003 and revised especially on the role of postoperative chemotherapy and the use of chemotherapeutic agents by the guideline committee of the Japan Lung Cancer Society in 2005. This guideline is divided into two parts as follows: 1) standard procedures for diagnostic techniques and treatment modalities such as surgery, chemotherapy and radiation therapy, the role of induction or adjuvant treatments for surgery and the approaches for central types of early bronchogenic cancer, and 2) standard adaptation of various methods of treatments according to the clinical stage. Now we are going to revise the guideline, renew the decision trees for standard treatment procedures and molecular targeted therapies based on the new TNM classification, and add parts to the treatments for malignant mesothelioma and the management of bone metastases with bisphosphonates.
Hayakawa
Kazushige
K
Department of Radiology, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara, Japan.
Tsuboi
Masahiro
M
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D009367:Neoplasm Staging; D017410:Practice Guidelines as Topic
D000970:Antineoplastic Agents